Literature DB >> 28098102

Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis.

Periyasamy Muthukumar1, Jeyachandran Dhanapriya1, Natarajan Gopalakrishnan1, Thanigachalam Dineshkumar1, Ramanathan Sakthirajan1, T Balasubramaniyan1.   

Abstract

The most common causes of renal disease in rheumatoid arthritis (RA) are glomerulonephritis (GN), amyloidosis, tubulo-interstitial nephritis, and drug toxicity. Our aim was to evaluate the clinicopathologic correlation of renal lesions and to assess the course and prognosis of renal disease in patients with RA. We conducted a prospective observational study in all adult patients with RA between July 2010 and June 2015. The total number of patients studied was 90, with a female:male ratio of 2.3:1. Mean follow-up duration was 30 ± 6.5 months. About 54 patients (60%) were asymptomatic. The most common symptom was edema legs (30%), followed by oliguria (10%). About 18 patients (20%) presented with the nephrotic syndrome, 15 patients (16.6%) with nephritic syndrome, and 30 (33%) with asymptomatic urinary abnormalities. Chronic kidney disease (CKD) was seen in 48 of 90 patients (53%).The most common renal pathology noted was mesangioproliferative GN followed by membranous nephropathy (MN). IgM with C3 deposits was the most common immunofluorescence pattern observed. Among the patients who had glomerular diseases, complete remission was seen in nine patients, partial remission in 15, and persistent proteinuria in 14. Duration of RA and a high erythrocyte sedimentation rate correlated significantly with persistent proteinuria. Only one patient in the glomerular disease group progressed to dialysis-dependent renal failure. On followup, 11 out of 48 CKD patients showed a significant decrease in estimated glomerular filtration rate and worsened to the next stage of CKD. Renal disease in RA presents with varied renal pathology. MN was seen frequently and was not associated with gold or penicillamine usage. Relatively high incidence of CKD was noted. Hence, it is important to monitor renal function abnormalities periodically in these patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28098102     DOI: 10.4103/1319-2442.198118

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  6 in total

1.  Membranous nephropathy caused by rheumatoid arthritis.

Authors:  Ayana Iida; Yukihiro Wada; Junichi Hayashi; Shohei Tachibana; Taro Inaba; Masayuki Iyoda; Kazuho Honda; Takanori Shibata
Journal:  CEN Case Rep       Date:  2019-04-29

2.  Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy.

Authors:  Yi Zhang; Yiqing Huang; Biao Huang; Xiaolei Chen; Bin Zhou; Pei Zou; Liang Wang; Xiaobin Liu; Huiming Sheng; Minhao Xie
Journal:  Biomed Res Int       Date:  2022-05-13       Impact factor: 3.246

3.  Renal dysfunction among rheumatoid arthritis patients: A retrospective cohort study.

Authors:  Ashraf O Oweis; Khaldoon M Alawneh; Sameeha A Alshelleh; Fatima Alnaimat; Diala Alawneh; Deeb Jamil Zahran
Journal:  Ann Med Surg (Lond)       Date:  2020-11-04

Review 4.  Medicinal Thiols: Current Status and New Perspectives.

Authors:  Annalise R Pfaff; Justin Beltz; Emily King; Nuran Ercal
Journal:  Mini Rev Med Chem       Date:  2020       Impact factor: 3.862

5.  Secondary Membranous Nephropathy. A Narrative Review.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-12-03

6.  Renal abnormalities in rheumatoid arthritis: an insight on IgA nephropathy.

Authors:  Ana R Prata; Helena Assunção; Gisela Eugénio; Vítor Sousa; Cátia Duarte
Journal:  Rheumatol Adv Pract       Date:  2021-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.